Arcus Biosciences, Inc.
RCUS
$9.34
-$0.20-2.10%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -45.83% | 23.08% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -45.83% | 23.08% | |||
Cost of Revenue | -17.89% | 1,130.00% | |||
Gross Profit | 0.00% | -358.62% | |||
SG&A Expenses | -6.67% | 0.00% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -15.69% | 5.52% | |||
Operating Income | 1.90% | 0.94% | |||
Income Before Tax | -1.09% | 1.08% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -2.17% | 1.08% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -2.17% | 1.08% | |||
EBIT | 1.90% | 0.94% | |||
EBITDA | 2.91% | 0.96% | |||
EPS Basic | -1.84% | 1.40% | |||
Normalized Basic EPS | -0.76% | 1.39% | |||
EPS Diluted | -1.84% | 1.40% | |||
Normalized Diluted EPS | -0.76% | 1.39% | |||
Average Basic Shares Outstanding | 0.33% | 0.33% | |||
Average Diluted Shares Outstanding | 0.33% | 0.33% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |